In addition, δ-catenin is expressed at high levels in >60% of patients with non-small cell lung cancer (9), and δ-catenin has been shown to promote a malignant phenotype in non-small cell lung cancer cell by affecting the activity of the transcriptional repressor Kaiso (10). The gene discussed is ZBTB33; the disease is non-small cell lung carcinoma.